Top Markets
Coin of the day
BNB Plus Corp. BNB Plus Corp.

BNB Plus Corp.

BNBX
Rang in aandelen #38647
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a... BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Aandeelprijs
$0.09
Laatst gesynchroniseerd: 2026-07-28
Marktkapitalisatie
$876.21K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-97.79%
Land
US
Handel BNB Plus Corp. (BNBX)

Categorie

Dividendrendementgeschiedenis voor BNB Plus Corp. (BNBX)
Het dividendrendement (TTM) van BNB Plus Corp. (aandelsymbool: BNBX) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van BNB Plus Corp. (BNBX) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten